The increasingly blurry lines between Germany’s medical and recreational cannabis markets are continuing to cause conflict among lawmakers and industry
Argent BioPharma Argent Biopharma (previously MGC Pharmaceuticals) has completed a US$4.5 million capital raise to support its drug development
Thousands of French medical cannabis patients have been given a temporary reprieve, enabling them to continue accessing their treatment for another six months.Â
Written by Ben Stevens and Sarah Sinclair. You can read Part 1 here. Growing demand for medical cannabis across Europe
Written by Ben Stevens and Sarah Sinclair. 2024 has been a dramatic year for the global cannabis industry, seeing
In a landmark moment for the Greek medical cannabis industry, Tikun Olam Europe, the 1st Medical Cannabis Company in Greece, sets new standards and achieves another first by completing the 1st export of finished medical cannabis products from Greece
Creating a culture that focuses on the behaviours required to achieve the results desired, has been the root cause of Releaf’s success in the UK’s medical cannabis sector – a sector that has stagnated since medical cannabis became legal in 2018.
British American Tobacco Tobacco giant British American Tobacco (BAT) has announced the launch of a second investment fund as
French patient associations have warned that medical cannabis patients could soon face a disruption in treatment as its long-running experiment
Last week, UK Prime Minister Keir Starmer committed to building 1.5 million homes over the current parliament, targeting the construction of 300,000 homes annually to align with long-advocated figures to address under-supply.Â
We won’t spam you
© 2024 Prohibition Holdings Ltd. All Rights Reserved.
© 2023 Prohibition Holdings Ltd. All Rights Reserved.